01 Expansion of CBD Products Across Specialized Pet Wellness Categories The CBD pet market is expanding beyond conventional oils and tinctures into a wider range of product formats designed for companion animal wellness. Manufacturers are introducing CBD-infused chews, treats, capsules, topical products, and other convenient formulations to address different administration preferences among pet owners. Product diversification is helping companies broaden their offerings across the expanding pet wellness sector. In March 2026, pet wellness companies continued expanding cannabinoid-based product portfolios through specialized formats designed for companion animals.
02 Growing Consumer Preference for Transparent Labeling and Verified Product Information Pet owners are increasingly evaluating CBD products based on ingredient disclosure, cannabinoid-content information, certificates of analysis, and third-party testing. Greater access to product information is becoming an important factor in purchasing decisions as consumers seek clearer visibility into what products contain and how they are manufactured. Brands that provide transparent labeling and independently verified information are increasingly using these practices to strengthen consumer confidence and market differentiation. In July 2026, CBD pet product brands continued emphasizing transparent labeling, ingredient disclosure, and independently verified product information to strengthen consumer confidence.
01 Increasing Consumer Spending on Companion Animal Health and Wellness Growing expenditure on pet health, nutrition, grooming, and wellness products is supporting demand for specialized companion animal products. Many pet owners increasingly view pets as integral members of their households and are seeking a broader range of products to support everyday care and wellness. This expansion in consumer spending on companion animal wellness remains an important driver of the CBD pet market.
01 Regulatory Uncertainty Surrounding Cannabinoid-Based Products for Animals The regulatory environment for CBD and other cannabinoid-based products intended for animals remains complex and varies across different markets. Requirements concerning permitted ingredients, veterinary recommendations, product classification, labeling, and marketing claims can create uncertainty for manufacturers and distributors. These evolving regulatory conditions can limit investment and complicate wider commercial expansion.
01 Expansion Through Specialized Pet Retail and Veterinary-Adjacent Distribution Channels Specialized pet retailers, animal wellness platforms, and veterinary-adjacent distribution channels could create opportunities for CBD pet brands to reach more targeted consumer groups. These channels can support better product education and provide access to pet owners seeking specialized wellness products. The development of focused distribution networks therefore represents a potential growth opportunity for companies operating in the CBD pet market.
01 Limited Scientific Evidence and Lack of Harmonized Dosage Standards A major challenge for the CBD pet market is the limited availability of consistent scientific evidence across different animal species, product formulations, and intended uses. Variations in cannabinoid concentrations, administration methods, and animal characteristics can make it difficult to establish broadly accepted dosage approaches. The absence of harmonized scientific, clinical, and industry standards can also complicate product development and market confidence. Strengthening research and developing more consistent frameworks for evaluating cannabinoid-based products remains a significant challenge for the CBD pet market.
In January 2026, cbdMD completed the strategic acquisition of Bluebird Botanicals and raised approximately USD 2.25 million in Series C financing.
In October 2025, CR Wellness announced a partnership with the global cannabis brand Cookies to bring premium cannabis and CBD wellness products to Brazil, marking an international market entry and collaboration aimed at expanding product reach and brand presence in South America.
In October 2025, CBD Life Sciences Inc. launched a mushroominfused “Dubai Chocolate Bar” combining adaptogens with CBD, targeting upscale functional confections.